Real-time enrollment status for this acute lymphoblastic leukemia clinical trial
Current Status
Active, Not Recruiting
Checked: June 2, 2026 at 2:10 AM UTC
| NCT Number | NCT03319901 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Acute Lymphoblastic Leukemia |
| Phase | Clinical Trial |
| Target Enrollment | 82 participants |
| Active Locations | 5 sites in the US |
| Sponsor | Dana-Farber Cancer Institute |
| Last Updated on CT.gov | June 1, 2026 (Yesterday) |
As of June 2, 2026: Clinical trial NCT03319901 is currently active_not_recruiting participants. This clinical trial study for acute lymphoblastic leukemia is not currently accepting new participants at 5 locations across the United States. The study is sponsored by Dana-Farber Cancer Institute. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT03319901 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03319901 was last updated Yesterday (June 1, 2026). HelloStudys verifies this status automatically.